אודות
פרסומים
- Generalized mean residual life models for survival data with missing censoring indicators, Li, W., Ma, H., Faraggi, D. & Dinse, G. E., 10 Feb 2023, In: Statistics in Medicine. 42, 3, p. 264-280 17 p.
- Cancer of the Cervix in Bulgaria: Epidemiology of a Crisis, Yordanov, A., Vasileva-Slaveva, M., Galai, N., Faraggi, D., Kubelac, M. P., Tripac-Iacovleva, I., Calleja, N., Di Fiore, R. & Calleja-Agius, J., Feb 2023, In: Healthcare (Switzerland). 11, 3, 318.
- Gynocare update: Modern strategies to improve diagnosis and treatment of rare gynecologic tumors—current challenges and future directions, Di Fiore, R., Suleiman, S., Calleja-Agius, J., Ellul, B., O’toole, S. A., Savona-Ventura, C., Felix, A., Napolioni, V., Conlon, N. T., Kahramanoglu, I., Azzopardi, M. J., Calleja, N., Dalmas, M., Brincat, M. R., Muscat-Baron, Y., Sabol, M., Dimitrievska, V., Yordanov, A., Vasileva-Slaveva, M. & von Brockdorff, K. & 14 others, , 2021, In: Cancers. 13, 3, p. 1-14 14 p., 493.
- Complications and safety of preconception low-dose aspirin among women with prior pregnancy losses, Ahrens, K. A., Silver, R. M., Mumford, S. L., Sjaarda, L. A., Perkins, N. J., Wactawski-Wende, J., Galai, N., Townsend, J. M., Lynch, A. M., Lesher, L. L., Faraggi, D., Zarek, S. & Schisterman, E. F., 1 Apr 2016, In: Obstetrics and Gynecology. 127, 4, p. 689-698 10 p.
- Sex ratio following preconception low-dose aspirin in women with prior pregnancy loss, Radin, R. G., Mumford, S. L., Silver, R. M., Lesher, L. L., Galai, N., Faraggi, D., Wactawski-Wende, J., Townsend, J. M., Lynch, A. M., Simhan, H. N., Sjaarda, L. A., Perkins, N. J., Zarek, S. M., Schliep, K. C. & Schisterman, E. F., 1 Sep 2015, In: Journal of Clinical Investigation. 125, 9, p. 3619-3626 8 p.
- Adjusting ROC curves for covariates in the presence of verification bias, Fluss, R., Reiser, B. & Faraggi, D., Jan 2012, In: Journal of Statistical Planning and Inference. 142, 1, p. 1-11 11 p.
- Diabetes, but not the metabolic syndrome, predicts the severity and extent of coronary artery disease in women, Zornitzki, T., Ayzenberg, O., Gandelman, G., Vered, S., Yaskil, E., Faraggi, D., Caspi, A., Goland, S., Shvez, O., Schattner, A. & Knobler, H., Sep 2007, In: QJM: An International Journal of Medicine. 100, 9, p. 575-581 7 p.
- Comparing the areas under two correlated ROC curves: Parametric and non-parametric approaches, Molodianovitch, K., Faraggi, D. & Reiser, B., Aug 2006, In: Biometrical Journal. 48, 5, p. 745-757 13 p.
- Heart rate variability (HRV) of patients with traumatic brain injury (TBI) during the post-insult sub-acute period, Keren, O., Yupatov, S., Radai, M. M., Elad-Yarum, R., Faraggi, D., Abboud, S., Ring, H. & Groswasser, Z., 10 Aug 2005, In: Brain Injury. 19, 8, p. 605-611 7 p.
- Competing Risks, Faraggi, D. & Reiser, B., 2005, The Encyclopaedic Companion to Medical Statistics. p. 65- 66
- Area under the Curve (AUC), Faraggi, D. & Reiser, B., 2005, The Encyclopaedic Companion to Medical Statistics. p. 12-13
- Frailty, Faraggi, D. & Reiser, B., 2005, The Encyclopaedic Companion to Medical Statistics. p. 140-141
- Receiver Operating Characteristic (ROC) Curve, Faraggi, D. & Reiser, B., 2005, The Encyclopaedic Companion to Medical Statistics. p. 295-296
- Adjusting the generalized ROC curve for covariates, Schisterman, E. F., Faraggi, D. & Reiser, B., 15 Nov 2004, In: Statistics in Medicine. 23, 21, p. 3319-3331 13 p.
- ROC curve analysis for biomarkers based on pooled assessments, Faraggi, D., Reiser, B. & Schisterman, E. F., 15 Aug 2003, In: Statistics in Medicine. 22, 15, p. 2515-2527 13 p.
- Confidence intervals for the 50 per cent response dose, Faraggi, D., Izikson, P. & Reiser, B., 30 Jun 2003, In: Statistics in Medicine. 22, 12, p. 1977-1988 12 p.
- Understanding neural networks using regression trees: An application to multiple myeloma survival data (multiple letters), Marshall, R. J., Faraggi, D., LeBlanc, M. & Crowley, J., 28 Feb 2003, In: Statistics in Medicine. 22, 4, p. 661 1 p.
- Adjusting receiver operating characteristic curves and related indices for covariates, Faraggi, D., 2003, In: Journal of the Royal Statistical Society Series D: The Statistician. 52, 2, p. 179-192 14 p.
- Misclassification in logistic regression with discrete covariates, Davidov, O., Faraggi, D. & Reiser, B., 2003, In: Biometrical Journal. 45, 5, p. 541-553 13 p.
- Phase II study of gemcitabine combined with radiation therapy in patients with localized, unresectable pancreatic cancer, Epelbaum, R., Rosenblatt, E., Nasrallah, S., Faraggi, D., Gaitini, D., Mizrahi, S. & Kuten, A., 1 Nov 2002, In: Journal of Surgical Oncology. 81, 3, p. 138-143 6 p.
- Estimation of the area under the ROC curve, Faraggi, D. & Reiser, B., 30 Oct 2002, In: Statistics in Medicine. 21, 20, p. 3093-3106 14 p.
- The association of hormone replacement therapy and coronary calcium as determined by electron beam tomography, Schisterman, E. F., Gallagher, A. M., Merz, C. N. B., Whitcomb, B. W., Faraggi, D., Moysich, K. B. & Lewin, H., 2002, In: Journal of Women's Health and Gender-Based Medicine. 11, 7, p. 631-638 8 p.
- Understanding neural networks using regression trees: An application to multiple myeloma survival data, Faraggi, D., LeBlanc, M. & Crowley, J., 15 Oct 2001, In: Statistics in Medicine. 20, 19, p. 2965-2976 12 p.
- Statistical inference for the area under the receiver operating characteristic curve in the presence of random measurement error, Schisterman, E. F., Faraggi, D., Reiser, B. & Trevisan, M., 15 Jul 2001, In: American Journal of Epidemiology. 154, 2, p. 174-179 6 p.
- The chemotherapeutic treatment of advanced Hodgkin's disease, Epelbaum, R., Haim, N., Ben-Shahar, M., Valtuch, I., Faraggi, D., Sharabi-Nov, A., Ben-Arie, Y. & Cohen, Y., 2001, In: Harefuah. 140, 4, p. 311-315+367
- Methodological issues associated with tumor marker development: Biostatistical aspects, Faraggi, D. & Kramar, A., Sep 2000, In: Urologic Oncology: Seminars and Original Investigations. 5, 5, p. 211-213 3 p.
- The effect of random measurement error on receiver operating characteristic (ROC) curves, Faraggi, D., 15 Jan 2000, In: Statistics in Medicine. 19, 1, p. 61-70 10 p.
- Nonparametric estimation of weighted proportions with application to particle size measurement, Goldenshluger, A. & Faraggi, D., 2000, In: Biometrika. 87, 1, p. 157-171 15 p.
- Criteres ROC generalises pour l'evaluation de plusieurs marqueurs tumoraux,
Kramar, A., Faraggi, D., Ychou, M., Reiser, B. & Grenier, J., Sep 1999, In: Revue d'Epidemiologie et de Sante Publique. 47, 4, p. 376-383 8 p.Translated title of the contribution :The generalized ROC criterion for the evaluation of several tumor markers - Lymphocyte subpopulations in patients with multiple primary tumors, Robinson, E., Segal, R., Struminger, L., Faraggi, D., El'ad-Yarum, R. & Mekori, T., 1 May 1999, In: Cancer. 85, 9, p. 2073-2076 4 p.
- Distribution of serum creatine kinase activity in young healthy persons, Lev, E. I., Tur-Kaspa, I., Ashkenazy, I., Reiner, A., Faraggi, D., Shemer, J. & Argov, Z., 1 Jan 1999, In: Clinica Chimica Acta. 279, 1-2, p. 107-115 9 p.
- Confidence intervals for the overlapping coefficient: The normal equal variance case, Reiser, B. & Faraggi, D., 1999, In: Journal of the Royal Statistical Society Series D: The Statistician. 48, 3, p. 413-418 6 p.
- Haptoglobin-related protein as a serum marker in malignant lymphoma, Epelbaum, R., Shalitin, C., Segal, R., Valansi, C., Arselan, I., Faraggi, D., Leviov, M., Ben-Shahar, M. & Haim, N., 1998, In: Pathology and Oncology Research. 4, 4, p. 271-276 6 p.
- Dexamethasone, etoposide, ifosfamide, and cisplatin as second-line therapy in patients with aggressive non-Hodgkin's lymphoma, Haim, N., Ben-Shahar, M., Faraggi, D., Tsuri-Etzioni, A., Leviov, M. & Epelbaum, R., 15 Nov 1997, In: Cancer. 80, 10, p. 1989-1996 8 p.
- Bayesian neural network models for censored data, Faraggi, D., Simon, R., Yaskil, E. & Kramar, A., 1997, In: Biometrical Journal. 39, 5, p. 519-532 14 p.
- A simulation study of cross-validation for selecting an optimal cutpoint in univariate survival analysis, Faraggi, D. & Simon, R., 30 Oct 1996, In: Statistics in Medicine. 15, 20, p. 2203-2213 11 p.
- Brain Stem Auditory Evoked Potentials: Effects of Ovarian Steroids Correlated with Increased Incidence of Bell's Palsy in Pregnancy, David, Y. B., Tal, J., Podoshin, L., Fradis, M., Sharf, M., Pratt, H. & Faraggi, D., Jul 1995, In: Otolaryngology - Head and Neck Surgery. 113, 1, p. 32-35 4 p.
- Dynamic treatment allocation adjusting for prognostic factors for more than two treatments, Dror, S., Faraggi, D. & Reiser, B., 1995, In: Biometrics. 51, 4, p. 1338-1343 6 p.
- Full dose chop chemotherapy in elderly patients with non-hodgkin's lymphoma, Epelbaum, R., Haim, N., Leviov, M., Ben-Shahar, M., Ben-Arie, Y., Dror, Y. & Faraggi, D., 1995, In: Acta Oncologica. 34, 1, p. 87-91 5 p.
- Maximum Likelihood Neural Network Prediction Models, Faraggi, D. & Simon, R., 1995, In: Biometrical Journal. 37, 6, p. 713-725 13 p.
- The menstrual cycle and acute appendicitis, Eldar, S., Faraggi, D., Abrahamson, J. & Schein, M., 1995, In: European Journal of Surgery, Acta Chirurgica. 161, 12, p. 897-900 4 p.
- Confidence bounds for Pr(a’x b’y), Reiser, B. & Faraggi, D., 1 Jan 1994, In: Statistics. 25, 2, p. 107-111 5 p.
- Is the vestibular system affected by middle ear effusion?, Ben-David, J., Podoshin, L., Fradis, M. & Faraggi, D., Sep 1993, In: Otolaryngology - Head and Neck Surgery. 109, 3, p. 421-426 6 p.
- Additive reducts of real closed fields, Faraggi, D., Pillay, A. & Peterzil, K., 1992, In: Journal of Philosophical Logic. 57, 1, p. 109-117
- Cytosine arabinoside and cisplatin for advanced breast cancer. A phase II study of the cancer and leukemia group B, Oster, M. W., Schilsky, R. L., Faraggi, D., Korzun, A. H., Perry, M., Moore, A., Kalra, J., Wood, W. C. & Craig Henderson, I., 15 Oct 1991, In: Cancer. 68, 8, p. 1696-1698 3 p.
- Twenty-four-hour blood pressure control with isradipine in mild essential hypertension, Viskoper, J. R., Laszt, A. & Faraggi, D., Feb 1991, In: American Journal of Hypertension. 4, 2, p. 161S-162S
- A General Scheme for Sequential Treatment Allocation with Balancing for Prognostic Factors in Clinical Trials, Faraggi, D. & Reiser, B., 1 Jan 1991, In: Communications in Statistics Part B: Simulation and Computation. 20, 1, p. 243-253 11 p.
- Short-term cardiovascular effects of lisinopril [2], Oren, S., Faraggi, D. & Viskoper, J. R., 1991, In: Journal of Human Hypertension. 5, 5, p. 464-465 2 p.
- A program which determines mutagenic concentrations of chemical carcinogens via a diffusion bioassay, Awerbuch, T. E., Ryder, E. F. & Faraggi, D., Aug 1987, In: Computer Methods and Programs in Biomedicine. 25, 1, p. 31-38 8 p.
- Role of the papadakis estimator in one- and two-dimensional field trials, Draper, N. R. & Faraggi, D., Apr 1985, In: Biometrika. 72, 1, p. 223-226 4 p.
